Skip to content

Microvascular Response in Diabetes Mellitus

Microcirculation cutanée et Vasodilatation Induite Par la Pression Non-Nociceptive Chez Les diabètiques

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00160927
Enrollment
90
Registered
2005-09-12
Start date
2003-01-31
Completion date
2008-01-31
Last updated
2007-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus

Keywords

microcirculation, Laser doppler flowmetry, neuropathy, endothelial function

Brief summary

Vascular and neurological mechanisms are both likely to be involved in foot ulcer. We recently reported on the hand an original transient pressure-induced vasodilation (PIV) during a 5 mmHg/min increase of pressure strain using laser Doppler flowmetry. This physiological response to non noxious external local pressure strain is a widely protective cutaneous mechanism. The impairment of PIV in diabetic subjects may be relevant to the high prevalence of foot ulcer that occurs in these individuals. The aim of the project is to analyse the different physiopathological processes involved in PIV impairment in diabetic subjects as compared to matched controls.

Detailed description

The whole study is a prospective observational study of diabetic type 1 and type 2 subjects focusing on the various physical, physiopathological or pharmacological mechanisms that may interfere with the normal response of the cutaneous microcirculation.The study is currently conducted under various parallel groups of patients and control subjects matched on age and sexe. Techniques used for the study are only non-invasive investigations such as iontophoresis with laser doppler flowmetry, clinical and paraclinical non-invasive investigation of peripheral neuropathy, ultrasound imaging of peripheral arteries.

Interventions

DRUGactylcholine
DRUGsodium nitroprusside

Sponsors

Alfediam
CollaboratorOTHER
UNIVALOIRE
CollaboratorUNKNOWN
University Hospital, Angers
Lead SponsorOTHER_GOV

Study design

Observational model
CASE_CONTROL
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Diabetes

Exclusion criteria

* Non diabetic neuropathy * Peripheral arterial disease * pregnancy

Countries

France

Contacts

Primary ContactJean Louis Saumet, MD PhD
+33 (0) 241.35.36.89
Backup ContactPierre Abraham

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026